Larry Frye, CEORemote, continuous monitoring offers richer, real-world metrics and stronger statistical power. Achieving meaningful results depends on datasets that include outcomes validated against pathology-confirmed measures, a feature rarely found in digital health research.
To address these challenges, Life Analytics delivers this capability through its Life Analytics Monitoring Platform (LAMP), designed to enhance trial design, data capture, and analysis.
The platform’s adaptability enables its use across any trial type, whether involving healthy volunteers in early-phase studies or participants managing chronic or neurodegenerative conditions. Its device-agnostic design supports a wide range of sensors, making it equally effective for drug discovery, chronic disease research, and wellness-focused studies.
Through this approach, the platform captures a continuous, real-world picture of health and behavior across domains that matter, including mobility, cognition, sleep, socialization, physiology, and safety. It derives insights from data collected unobtrusively through connected devices, revealing whether someone is functioning better in their everyday environment.
“Our platform is HIPAA-compliant and offers a preselected set of biomarkers that capture critical patient information in real time while securely transferring this data to servers for ongoing monitoring of the patient’s condition,” says Larry Frye, CEO.
Patients are more likely to remember to take medications, sleep consistently, use devices effectively, and maintain better engagement. These changes are tracked using real-time biomarkers. This level of observation provides greater statistical power and allows researchers to detect changes with fewer patients. As a result, trials can progress more quickly while minimizing exposure to potential side effects.
Data is transmitted securely and converted into a format that integrates directly into trial systems. Sponsors receive it in SAS-compliant form, ensuring it flows smoothly into existing databases. Researchers can view the data through an interactive dashboard, enabling real-time review of individual or group outcomes. Changes in behavior and biomarker trends become visible, actionable, and measurable.
The platform is both device-agnostic and condition-agnostic. It can support any trial indication and compatible device, such as wearables, smart scales, or sleep mats. This flexibility allows trials to begin without costly delays or infrastructure hurdles. Devices are deployed remotely to patients’ homes, often without requiring a technician visit. If a patient drops out, a new one can be added without disrupting timelines.
-
Our platform is HIPAA compliant and offers a preselected set of biomarkers that capture critical patient information in real time, while securely transferring this data to servers for ongoing monitoring of the patient’s condition
Data is transmitted securely and converted into a format that integrates directly into trial systems. Sponsors receive it in SAS-compliant form, ensuring it flows smoothly into existing databases. Researchers can view the data through an interactive dashboard, enabling real-time review of individual or group outcomes. Changes in behavior and biomarker trends become visible, actionable, and measurable.
More than 1,000 households across the U.S., Canada, and France have already used LAMP in various studies. These include people living in assisted housing, rural veterans, diverse ethnic communities, and older adults in multiple environments. The platform has proven effective during public health emergencies and can identify changes such as mood decline or isolation before they become clinically observable.
Biomarkers from the platform have demonstrated predictive performance equal to or greater than traditional neuropsychological tests. Metrics such as medication adherence, gait speed, and mood variability deliver greater ecological relevance than task-based assessments. The platform’s digital outcomes have been validated through pathology-confirmed research, a scientific standard that enhances reliability and acceptance.
Patient-reported outcomes, such as improvements in pain or sleep, are supported by objective, time-stamped data, closing the gap between perception and measurement. The platform makes these observations continuously available rather than sporadic, giving clinical teams a valuable tool for managing outcomes.
This continuous stream of insights, backed by validated biomarkers and real-world evidence, gives researchers the clarity they need to act sooner, adjust faster, and design smarter trials. Life Analytics helps build studies that are more inclusive, more responsive, and more grounded in the way people actually live.
Clinical Trial Monitoring That Measures Real Life
Clinical development leaders face growing pressure to make trials faster, more inclusive and more evidence-driven without compromising scientific rigor. Traditional site-based monitoring often captures only a limited view of patient health, shaped by scheduled visits, retrospective reporting and isolated endpoint assessments. As a result, meaningful changes that occur between visits can go unnoticed, particularly in chronic disease studies where sleep, movement, adherence, pain, daily routines and physiologic fluctuations may provide earlier signals of treatment response than conventional evaluations. For sponsors, the challenge is no longer collecting more data. It is understanding whether that data is reliable, interpretable and useful while a study is still in progress.
A strong clinical trial analytics and monitoring platform should extend research into patients' daily lives while preserving the discipline required in regulated development. Continuous or high-frequency remote measurement creates value only when it reduces uncertainty instead of introducing more noise. Executives should aim to partner with platforms capable of consolidating biomarker and activity data across multiple devices, synthesizing this into sponsor-ready reports and extracting meaningful patient and cohort-level insights. Ideally, patient-reported data, pain reports, sleep quality, mobility and adherence reports should be analyzed in tandem with the observed data, and not simply as a single data point, and an effective system will facilitate this.
Data integration is just as important. Many life sciences organizations already manage fragmented information from wearables, imaging systems, electronic diaries, laboratory platforms and clinical databases. A monitoring solution that cannot normalize and contextualize these inputs risks becoming another disconnected dashboard instead of a meaningful decision-support tool. Robust platforms are multi-device enabled, align to clinical trial parameters and help in identifying trends, outliers and patient journey as you view them during study review while it's underway. The intention is not to create new areas to reconcile, but rather to eliminate 'blinding' for clinical operations that are already managing sites, subjects, monitors, and data management vendors.
This capability is particularly valuable in early-phase and proof-of-concept studies, where earlier signal detection can influence protocol refinement, patient selection and resource allocation. Real-time monitoring further enables teams to distinguish normal patient variability from a true therapeutic effect, providing clinical, data science and sponsor stakeholders with a clearer picture operationally before minor issues turn into larger protocol or portfolio issues.
Trust in these systems also depends on governance. Remote data collection introduces important considerations around patient privacy, data transfer, system validation and accountability for interpretation. Platforms should be secure by design, support HIPAA-aligned data handling practices and demonstrate research foundations that link digital measurements to clinically meaningful outcomes. The leading companies leverage much more than the novelty of technology. They demonstrate how home-based monitoring can enhance study design, increase patient participation, minimize the need for site visits and allow sponsors to evaluate treatment effect in a real-world environment.
Within this category, Life Analytics stands out as a particularly strong option for organizations evaluating advanced clinical trial monitoring capabilities. Its Life Analytics Monitoring Platform combines connected devices, communication systems, analytical algorithms and database infrastructure to measure home-based activity and behavioral change. The platform works with both medical-grade and consumer devices that support standard communication protocols or APIs while storing information on HIPAA-compliant servers. Key strengths include sponsor-ready clinical trial reporting, interactive real-time visualization, device-agnostic biomarker capture and support for patient-reported outcomes. For studies in neurology, chronic disease and decentralized research models, Life Analytics offers a focused approach to turning continuous patient-generated data into actionable clinical insight.
...Read more
Clinical Trials Life Analytics Monitoring Platform Info
Q1
What distinguishes Life Analytics among Top Clinical Trial Life Analytics Monitoring Platforms?
Life Analytics has earned recognition among Top Clinical Trial Life Analytics Monitoring Platforms through its ability to capture continuous, real-world patient data outside traditional clinical environments. Its Life Analytics Monitoring Platform (LAMP) enables researchers to monitor mobility, cognition, sleep, medication adherence, physiology and social engagement using connected technologies deployed directly in patients’ homes. This approach helps sponsors move beyond isolated clinic-based observations and gain a more comprehensive understanding of patient behavior over time. Life Analytics also differentiates itself through pathology-validated biomarkers and a device-agnostic infrastructure that supports flexible clinical trial deployment across diverse patient populations.
Q2
How does Life Analytics improve clinical trial monitoring and data collection?
Continuous remote monitoring forms the foundation of the company’s clinical trial strategy. Unlike many Clinical Trial Life Analytics Monitoring Platforms that rely heavily on episodic site visits, Life Analytics collects real-time behavioral and physiological data within patients’ everyday environments. Its platform integrates wearable devices, sleep sensors, smart scales and connected technologies into one unified monitoring ecosystem. The system then transforms this information into actionable biomarkers that help researchers track patient condition changes more efficiently. This continuous observation model improves data depth, enhances statistical power and supports faster trial decision-making with fewer participants.
Q3
Why is Life Analytics relevant to decentralized and hybrid clinical trials?
Modern clinical research increasingly depends on decentralized participation models, and Life Analytics directly addresses that transition through remote patient monitoring technology. Among Clinical Trial Life Analytics Monitoring Platforms, the company stands out for enabling studies to operate effectively without requiring frequent in-person clinic visits. Devices can be deployed directly to participants’ homes, reducing geographic barriers that often limit trial diversity and enrollment retention. This flexible infrastructure also supports studies involving older adults, rural communities and assisted living populations, helping sponsors create more inclusive and representative clinical trials.
Q4
What role does technology play in the Life Analytics Monitoring Platform?
Advanced data integration and analytics capabilities remain central to the LAMP ecosystem. The platform combines connected devices, proprietary study management software, secure data transmission systems and predictive algorithms developed through years of research. Life Analytics designed the platform to remain technology-agnostic, allowing compatibility with devices that use standard communication protocols or API-based integration. Clinical Trial Life Analytics Monitoring Platforms often differentiate themselves through scalability and interoperability, and Life Analytics reinforces that advantage through HIPAA-compliant infrastructure, real-time dashboards and SAS-compliant data outputs that integrate directly into existing trial systems.
Q5
How does Life Analytics support sponsors and research teams throughout clinical trials?
Integrated oversight tools allow Life Analytics to support sponsors from trial setup through ongoing patient monitoring and data analysis. Researchers can access interactive dashboards that display individual and group-level biomarker trends in real time, helping clinical teams identify changes in patient condition earlier than traditional monitoring methods. The company also simplifies logistics by remotely onboarding participants and managing device deployment without requiring on-site technical visits in many cases. Among Clinical Trial Life Analytics Monitoring Platforms, Life Analytics strengthens customer support through streamlined data integration, continuous monitoring visibility and adaptable deployment models suited for multiple study types.
Q6
Why has Life Analytics gained visibility in clinical research and digital health?
Industry recognition for Life Analytics reflects its contribution to real-world evidence generation and digital biomarker research. The company’s platform has already supported studies across the United States, Canada and France involving diverse participant populations and multiple clinical applications. Its biomarkers have demonstrated predictive performance comparable to or exceeding traditional neuropsychological assessments in certain research settings. This combination of validated digital monitoring, inclusive trial enablement and continuous patient observation has strengthened Life Analytics’ reputation among Clinical Trial Life Analytics Monitoring Platforms focused on advancing decentralized clinical research and real-time health analytics.
